bioRxiv preprint doi: https://doi.org/10.1101/190892; this version posted February 3, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Integration of human pancreatic islet genomic data refines 2 regulatory mechanisms at Type 2 Diabetes susceptibility loci 3 Matthias Thurner1,2, Martijn van de Bunt1,2, Jason M Torres1, Anubha Mahajan1, 4 Vibe Nylander2, Amanda J Bennett2, Kyle Gaulton3, Amy Barrett2, Carla Burrows2, 5 Christopher G Bell4,5, Robert Lowe6, Stephan Beck7, Vardhman K Rakyan6, Anna L 6 Gloyn1,2,8, Mark I McCarthy*1,2,8 7 8 1. The Wellcome Trust Centre for Human Genetics, University of Oxford, UK 9 2. Oxford Centre for Diabetes, Endocrinology and Metabolism, University, of 10 Oxford, Oxford, UK 11 3. Department of Pediatrics, University of California, San Diego, US 12 4. Department of Twin Research & Genetic Epidemiology, Kings College London, 13 London, UK 14 5. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, 15 UK 16 6. Centre for Genomics and Child Health, Blizard Institute, Barts and The London 17 School of Medicine and Dentistry, London, UK 18 7. Department of Cancer Biology, UCL Cancer Institute, University College 19 London, London, UK 20 8. Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK 21 22 *Corresponding author (
[email protected]) 23 24 Abstract 25 Human genetic studies have emphasised the dominant contribution of 26 pancreatic islet dysfunction to development of Type 2 Diabetes (T2D).